The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
VEGF enhances angiogenesis and promotes blood–brain barrier leakage in the ischemic brain
Open accessAbstract
VEGF is a secreted mitogen associated with angiogenesis and is also a potent vascular permeability factor. The biological role of VEGF in the ischemic brain remains unknown. This study was undertaken to investigate whether VEGF enhances cerebral microvascular perfusion and increases blood-brain barrier (BBB) leakage in the ischemic brain. Using magnetic resonance imaging (MRI), three-dimensional laser-scanning confocal microscope, and functional neurological tests, we measured the effects of administrating recombinant human VEGF(165) (rhVEGF(165)) on angiogenesis, functional neurological outcome, and BBB leakage in a rat model of focal cerebral embolic ischemia. Late (48 hours) administration of rhVEGF(165) to the ischemic rats enhanced angiogenesis in the ischemic penumbra and significantly improved neurological recovery. However, early postischemic (1 hour) administration of rhVEGF(165) to ischemic rats significantly increased BBB leakage, hemorrhagic transformation, and ischemic lesions. Administration of rhVEGF(165) to ischemic rats did not change BBB leakage and cerebral plasma perfusion in the contralateral hemisphere. Our results indicate that VEGF can markedly enhance angiogenesis in the ischemic brain and reduce neurological deficits during stroke recovery and that inhibition of VEGF at the acute stage of stroke may reduce the BBB permeability and the risk of hemorrhagic transformation after focal cerebral ischemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As a pleiotropic growth factor, VEGF is responsible for multiple important physiological functions, particularly BBB permeability [44, 50, 51].”
From Chronic stress-induced depression requires the recruitment of peripheral Th17 cells into the brain (2022) · cites this paper as [50]
Experimental — accuracy not yet measuredIn the citing paper
“Similar findings about the importance of timing for administration of a neurorestorative therapy for stroke have been reported for VEGF94 and modulators of matrix metallo proteinases.95”
From Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation (2012) · cites this paper as [94]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Le Bihan, D., Breton, E., Lallemand, D., Grenier, P., Cabanis, E., & Laval-Jeantet, M. (1986) · Radiology · doi:10.1148/radiology.161.2.3763909 · Cited by 3,912
Dvorak, H. F., Brown, L. F., Detmar, M. J., & Dvořàk, A. M. (1995) · Europe PMC (PubMed Central) · Cited by 3,100
FINE STRUCTURAL LOCALIZATION OF A BLOOD-BRAIN BARRIER TO EXOGENOUS PEROXIDASE
Reese, T. S., & Karnovsky, M. J. (1967) · The Journal of Cell Biology · doi:10.1083/jcb.34.1.207 · Cited by 2,629
Magnetic resonance imaging of perfusion using spin inversion of arterial water.
Williams, D. S., Detre, J. A., Leigh, J. S., & Koretsky, A. P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.212 · Cited by 1,553
Leakage-Resistant Blood Vessels in Mice Transgenically Overexpressing Angiopoietin-1
Thurston, G., Suri, C., Smith, K., McClain, J., Sato, T. T., Yancopoulos, G. D., & McDonald, D. M. (1999) · Science · doi:10.1126/science.286.5449.2511 · Cited by 1,350
Angiopoietin-1 protects the adult vasculature against plasma leakage
Thurston, G., Rudge, J. S., Ioffe, E., Zhou, H., Ross, L. H., Croll, S. D., Glazer, N. L., Holash, J. A., McDonald, D. M., & Yancopoulos, G. D. (2000) · Nature Medicine · doi:10.1038/74725 · Cited by 1,314
Peptide Growth Factors and Their Receptors
Arai, K., Battey, J. F., Sporn, M. B., & Roberts, A. B. (1991) · Medical Entomology and Zoology · Cited by 1,225
Breier, G., Albrecht, U., Sterrer, S., & Risau, W. (1992) · Development · doi:10.1242/dev.114.2.521 · Cited by 1,087
Takeshita, S., Zheng, L., Brogi, E., Kearney, M., Pu, L. L. Q., Bunting, S., Ferrara, N., Symes, J. F., & Isner, J. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117018 · Cited by 1,034
A functional MRI study of subjects recovered from hemiparetic stroke
Cramer, S. C., Nelles, G., Benson, R. R., Kaplan, J. D., Parker, R. A., Kwong, K. K., Kennedy, D. N., Finklestein, S. P., & Rosen, B. R. (1997) · Stroke · doi:10.1161/01.str.28.12.2518 · Cited by 1,019
Research works printed but not linked: 8
- Carmeliet, 1997, Am J Physiol, 273, H2091
- Aiello, 1997, Invest Ophthalmol Vis Sci, 38, 1647
- Dvorak, 1995, Am J Pathol, 146, 1029
- Hatashita, 1990, Adv Neurol, 52, 327
- Lyden, 1993, Cerebrovasc Brain Metab Rev, 5, 1
- Dellian, 1996, Am J Pathol, 149, 59
- Cancilla, 1979, Lab Invest, 40, 74
- Criscuolo, 1990, Adv Neurol, 52, 469
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Hazell, A. S., Wang, D., Oanea, R., Sun, S., Aghourian, M., & Yong, J. J. (2013) · Metabolic Brain Disease · doi:10.1007/s11011-013-9436-9 · Cited by 12
“This may be significant in that endothelial cell proliferation triggered by elevated expression of VEGF from astrocytes and neurons occurs soon after brain injury and is suggested to enhance angiogenesis and decrease the infarct region (Marti et al. 2000; Zhang et al. 2000; Hayashi et al. 2003).”
BackgroundKhalifa, A. G., Moselhy, W. A., Mohammed, H. M., Khalıl, F., Shaban, M., El‐Nahass, E., Al-Muzafar, H. M., Amin, K. A., & Abdou, K. A. H. (2022) · Toxics · doi:10.3390/toxics10060303 · Cited by 12
“VEGF was able to stimulate angiogenesis [61] and promote the neuronal precursor’s proliferation [62].”
BackgroundShu, B., Wan, J., Li, X., Liu, R., Xu, C., An, Y., & Chen, J. (2022) · Cellular Reprogramming · doi:10.1089/cell.2022.0037 · Cited by 12
“5A), VEGF (Fig.”
InfluentialLapi, D., Vagnani, S., Sapio, D., Mastantuono, T., Sabatino, L., Paterni, M., & Colantuoni, A. (2013) · Journal of Vascular Research · doi:10.1159/000353295 · Cited by 12
A pre-injury high ethanol intake in rats promotes brain edema following traumatic brain injury
Wu, W., Tian, R., Hao, S., Xu, F., Mao, X., & Liu, B. (2014) · British Journal of Neurosurgery · doi:10.3109/02688697.2014.915007 · Cited by 12
ENOS and Stroke: Prevention, Treatment and Recovery
Gertz, K. R., & Endres, M. (2008) · Future Neurology · doi:10.2217/14796708.3.5.537 · Cited by 11
“VEGF administered within 1 h after stroke resulted in a worse outcome by increasing vascular permeability, but VEGF administration at 48 h after ischemia improved angiogenesis in the ischemic penumbra and neurological outcome [116].”
BackgroundVEGF mimic peptides: Potential applications in central nervous system therapeutics
D’Andrea, L. D., Rosa, L. D., Vigliotti, C., & Cataldi, M. (2016) · European Journal of Molecular & Clinical Medicine · doi:10.1016/j.nhtm.2016.12.002 · Cited by 12
Biomaterials driving repair after stroke
Tuladhar, A., & Shoichet, M. S. (2018) · Nature Materials · doi:10.1038/s41563-018-0124-3 · Cited by 12
Protein Tyrosine Phosphorylation in the Ischemic Brain
Takagi, N. (2014) · Journal of Pharmacological Sciences · doi:10.1254/jphs.14r04cp · Cited by 12
Zakareia, F. A., AL-Ayadhi, L. Y., & Al-Drees, A. A. (2012) · Neurosciences · doi:10.17712/1658-3183.1949 · Cited by 12
Foster, K. A., Regan, H. K., Danziger, A., Detwiler, T. J., Kwon, N., Rickert, K. W., Lynch, J. J., & Regan, C. P. (2008) · Neuroscience Research · doi:10.1016/j.neures.2008.09.007 · Cited by 12
“Previously in a rat model of focal cerebral embolic ischemia, early VEGF administration increased BBB leakage, hemorrhagic transformation and ischemic injury, whereas delayed administration improved neurological performance (Zhang et al., 2000).”
Lo, A., Lai, A. K. W., Ng, T. C., Hung, V., Tam, K. C., Cheung, C., & Chung, S. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.330612 · Cited by 12
“The deleterious role of VEGF reported in rodents after stroke includes increasing infarct volume, blood-brain barrier breakdown, and hemorrhagic transformation (Zhang et al., 2000; Kaya et al., 2005).”
BackgroundEvaluation of BCAS1-positive immature oligodendrocytes after cerebral ischemic stroke and SVD
Jiang, G., Ayaki, T., Maki, T., Yasuda, K., Yoshii, D., Kaji, S., & Takahashi, R. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137405 · Cited by 11
Serum level of vascular endothelial growth factor decreased in chronic ketamine abusers
Fan, N., Zhang, M., Xu, K., Ke, X., Ding, Y., Wang, D., Liu, Y., Ning, Y., Deng, X., & He, H. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.04.022 · Cited by 11
Quan, F.-S., Chen, J., Zhong, Y., & Ren, W. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3527 · Cited by 11
Nezhad, N. J., Safari, A., Namavar, M. R., Nami, M., Karimi‐Haghighi, S., Pandamooz, S., Dianatpour, M., Azarpira, N., Khodabandeh, Z., Zare, S., et al. (2023) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2023.107202 · Cited by 11
Regeneration of Neuronal Cells following Cerebral Injury
Dailey, T., Tajiri, N., Kaneko, Y., & Borlongan, C. V. (2013) · Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences · doi:10.1159/000346407 · Cited by 11
Temporal alteration of serum G-CSF and VEGF levels in perinatal asphyxia treated with head cooling
Okazaki, K., Kusaka, T., Kondo, M., Kozawa, K., Yoshizumi, M., & Kimura, H. (2012) · Cytokine · doi:10.1016/j.cyto.2012.08.001 · Cited by 11
Bosomtwi, A., Chopp, M., Zhang, L., Zhang, Z. G., Lü, M., & Jiang, Q. (2011) · Brain Research · doi:10.1016/j.brainres.2011.01.009 · Cited by 11
“…VEGF receptor 2 (VEGFR2) initiate angiogenesis, while angiopoietins 1 and 2 and their receptor, Tie2 are involved in vessel maturation, stabilization, and remodeling (Chen et al., 2001; Zhang et al., 2002b) and mediate angiogenesis at the ischemic boundary (Zhang et al., 2000; Zhang et al., 2002b).”
BackgroundInfluentialSelf-citationZhang, G., Wang, R., Cheng, K., Li, Q., Wang, Y., Zhang, R., & Qin, X. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00504 · Cited by 11
“Angiogenesis induced by VEGF in rats was associated with reduced neurological deficits after focal cerebral ischemia (27).”
BackgroundSelf-citationEffect of Combination Therapy with Neuroprotective and Vasoprotective Agents on Cerebral Ischemia
Yang, J., Yang, B., Xiu, B., Qi, J., & Liu, H. (2018) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2018.8 · Cited by 11
“A series of studies have documented that VEGF is up-regulated in the ischemic brain after stroke, and exogenous VEGF is strongly angiogenic and neuroprotective.(25-31) Nerve growth factor can promote the survival of specific groups of neurons both in vivo and in vitro,(32-38) and has protective effects against neurona…”
BackgroundDecreased angiogenesis as a possible pathomechanism in cervical degenerative myelopathy
Blume, C., Geiger, M. F., Müller, M., Clusmann, H., Mainz, V., Kalder, J., Brandenburg, L., & Mueller, C. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-81766-8 · Cited by 11
Haque, A., Das, A., Samantaray, S., Matzelle, D. D., Capone, M., Wallace, G., Husarik, A. N., Taheri, S., Reiter, R. J., Varma, A. K., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042384 · Cited by 11
“Therefore, use of beneficial agents such as E2, melatonin, and VEGF that are capable of promoting microvessel growth and improving restoration of blood supply to the damaged area for cell survival is imperative [17,56,57].”
BackgroundIschemic Stroke: Basic Pathophysiology and Neuroprotective Strategies
Singhal, A. B., Lo, E. H., Dalkara, T., & Moskowitz, M. A. (2010) · Springer eBooks · doi:10.1007/978-3-642-12751-9_1 · Cited by 11
Mallolas, J., Rodríguez-Romanos, R., Gubern, C., Camós, S., Serena, J. L., & Castellanos, M. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8333-7 · Cited by 11
“VEGF can markedly enhance angiogenesis in the ischemic brain and reduce neurological deficits during stroke recovery, although VEGF is also a potent vascular permeability factor that increases microvascular permeability and HT after cerebral ischemia (Zhang et al. 2000).”
Park, Y. S., Cho, J. H., Kim, I. H., Cho, G., Cho, J.-H., Park, J. H., Ahn, J. H., Chen, B. H., Shin, B. N., Shin, M. C., et al. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.09.044 · Cited by 11
“It is documented that VEGF can increase cerebral vascular permeability, induce brain edema [50–52] and pro-inflammatory cell recruitment [53], which may be deleterious.”
Novel technologies for antiangiogenic drug delivery in the brain
Benny, O., & Pakneshan, P. (2009) · Cell Adhesion & Migration · doi:10.4161/cam.3.2.7766 · Cited by 11
Tuma, R. F. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374530-9.00013-9 · Cited by 11
Rab7a is required to degrade select blood-brain barrier junctional proteins after ischemic stroke
Cottarelli, A., Jamoul, D., Tuohy, M. C., Shahriar, S., Glendinning, M. D., Prochilo, G., Edinger, A. L., Arac, A., & Agalliu, D. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02125-6 · Cited by 10
“Post-isch-emic VEGF-A administration also increases BBB leakage and hemorrhagic transformation, while antagonism of endogenous VEGF-A reduces infarct volume [63, 64].”
Zhang, X., Huang, K., Wu, Z., Ding, R., Han, J., Zhang, Y., Lu, Y., Lu, Y., & Si, Y. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108971 · Cited by 12
Pranty-Weßelmann, A. I., Szepanowski, L.-P., Wruck, W., Karikari, A. A., & Adjaye, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-76259-3 · Cited by 12
“…which are reported to modify cell junctions, increase endothelial permeability and enhance leukocyte trans-endothelial migration in inflammation 41-44 are key elements to HMZ induced cellular injury in CM. Ultimately, the significant expression of these factors represents inflammation and…”
BackgroundVEGF‐E Attenuates Injury After Ischemic Stroke by Promoting Reparative Revascularization
Menet, R., Nasrallah, L., Bernard, M., Allain, A., & ElAli, A. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70114 · Cited by 12
The effects of doxorubicin on blood-brain barrier integrity in hCMEC/D3
Patel, C., Glytsou, C., Jang, M.-H., & Cole, P. D. (2025) · NeuroToxicology · doi:10.1016/j.neuro.2025.103355 · Cited by 10
“Mitochondria play an important role in the VEGF pathway, which is considered as a key mediator of angiogenesis (Wang et al., 2023); in ischemic rats, VEGF increased angiogenesis and reduced neurological deficits (Zhang et al., 2000).”
Bakhtiary, M., Marzban, M., Mehdizadeh, M., Joghataei, M. T., Khoei, S., Tondar, M., Mahabadi, V. P., Laribi, B., Asghar, E., Hashemian, S. J., et al. (2011) · Europe PMC (PubMed Central) · Cited by 10
An exploratory assessment of serum biomarkers of post-cardiac arrest syndrome in children
Kernan, K. F., Berger, R. P., Clark, R. S. B., Watson, R. S., Angus, D. C., Panigrahy, A., Callaway, C. W., Bell, M. J., Kochanek, P. M., Fink, E. L., et al. (2021) · Resuscitation · doi:10.1016/j.resuscitation.2021.07.007 · Cited by 10
Tobieson, L., Gard, A., Ruscher, K., & Marklund, N. (2021) · Neurocritical Care · doi:10.1007/s12028-021-01389-9 · Cited by 10
“VEGF-A, which mediates increased permeability of the blood–brain barrier [48, 49], was distinctly higher in PHZ compared with SNX, which may then potentially aggravate vasogenic edema and cause further secondary brain injury.”
Glial Populations in the Human Brain Following Ischemic Injury
Mihailova, V., Stoyanova, I. I., & Tonchev, A. B. (2023) · Biomedicines · doi:10.3390/biomedicines11092332 · Cited by 11
Chapter 6 Reperfusion injury after stroke: neurovascular proteases and the blood–brain barrier
Ning, M., Wang, X., & Lo, E. H. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(08)01906-4 · Cited by 10
Roslavtceva, V., Salmina, A. B., Prokopenko, S. V., Пожиленкова, Е. А., Кобаненко, И. В., & Rezvitskaya, G. G. (2016) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20166202124 · Cited by 10
Self-assembling Molecular Medicine for the Subacute Phase of Ischemic Stroke
Muraoka, T., & Ajioka, I. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03638-5 · Cited by 10
“In 2000, Chopp and coworkers demonstrated VEGF effects on angiogenesis and neurological recovery by the continuous intravenous administration from 48 h after the onset of rat ischemic stroke, suggesting the importance of continuous VEGF replenishment for the recovery at the subacute phase [51].”
BackgroundKang, K. A., Seong, H., Jin, H.-B., Park, J., Lee, J., Jeon, J. Y., & Kim, Y. (2011) · Journal of Korean Academy of Nursing · doi:10.4040/jkan.2011.41.2.197 · Cited by 10
“, 2005), BBB의 견고성을 유지하는 데 관여하며 뇌경색 유발 28일이 지난 후까지도 VEGF가 지속되면서 신생혈관 형성을 향상시킨다고 하였다(Zhang et al., 2000).”
Kōyama, Y., Hayashi, M., Nagae, R., Tokuyama, S., & Konishi, T. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12770 · Cited by 10
Shi, E., Jiang, X., Kazui, T., Washiyama, N., Yamashita, K., Terada, H., & Bashar, A. H. M. (2006) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2006.06.018 · Cited by 10
Kimura, K., Matsumoto, K., Ohtake, H., Oka, J., & Fujiwara, H. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.04.012 · Cited by 11
“Vascular endothelial growth factor (VEGF) is involved in angiogenesis and vasculogenesis and plays an important role in pathological and physiological phenomena such as wound healing, the menstrual cycle, and permeability of the blood brain barrier (Adini et al., 2017; Detmar et al., 1995; Ferrara, 2004; Greenberg and…”
Postischemic Angiogenic Factor Expression in Stroke-Prone Rats
Wang, M. M., Klaus, J. A., Joh, H.-D., Traystman, R. J., & Hurn, P. D. (2002) · Experimental Neurology · doi:10.1006/exnr.2001.7844 · Cited by 10
Tuma, R. F. (2008) · Comprehensive physiology · doi:10.1002/cphy.cp020411 · Cited by 9
Özbek, E., Adaş, G., Ötünçtemur, A., Duruksu, G., Koç, B., Polat, E. C., Sarvan, A. K., Okçu, A., Kamali, G. H., Subaşı, C., et al. (2015) · Experimental and Clinical Transplantation · doi:10.6002/ect.2014.0080 · Cited by 10
Ghorbanpour, S. M., Cartland, S. P., Chen, H., Seth, S., Ecker, R., Richards, C., Aksentijević, D., Padula, M. P., Cole, L., Warkiani, M. E., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06118-w · Cited by 9
“Because AD-01 and FKBPL can modulate the NF-ĸB signalling in response to inflammation, our findings suggest that AD-01 may also regulate NF-ĸB signalling via inhibition of the RIG-I-like receptors and VEGF-pathways [16,76–78].”
Shi, V., Wu, S., Lian, Q., Shi, R., Liu, Z., Xu, T., Deng, S., Shao, X., Beckmann, A., Li, W., et al. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70597 · Cited by 10
“…biological rationale: (1) NSC proliferation peaks at 7 to 14 days post-stroke [41], (2) angiogenesis begins within hours of stroke onset, also peaking at 7 to 14 days after stroke [15, 42], and (3) VEGF should be applied at least 48 h after stroke to avoid adverse effects like BBB leakage [43–45].”
Self-citationWang, J., Zhou, X., Lu, H., Song, M., Zhao, J., & Wang, Q. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13521 · Cited by 9
Perfusion and permeability as diagnostic biomarkers of cavernous angioma with symptomatic hemorrhage
Sone, J. Y., Li, Y., Hobson, N., Romanos, S. G., Srinath, A., Lyne, S. B., Shkoukani, A., Carrión‐Penagos, J., Stadnik, A., Piedad, K., et al. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x211020587 · Cited by 8
Μanthou, M. E., Nohroudi, K., Moscarino, S., Rehberg, F., Stein, G., Jansen, R., Abdulla, D., Jaminet, P., Semler, O., Schöenau, E., et al. (2015) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-140434 · Cited by 9
“Application of exogenous VEGF (vascular endothelial growth factor) an angiogenic substance to the spinal cord injury site in rats increased blood vessel density in the wound area, significantly improved tissue sparing and behaviour (Zhang et al., 2000).”
ALH-L1005 attenuates endotoxin induced inner ear damage
Jang, C. H., Cho, Y. B., Choi, C. H., Jang, Y. S., Jang, S. J., Jung, W., Park, B. Y., & Kim, M. Y. (2014) · International Journal of Pediatric Otorhinolaryngology · doi:10.1016/j.ijporl.2013.12.022 · Cited by 9
Mesenchymal stem cells for treatment of neurological disorders: a paracrine effect
Kim, M., Kim, K. H., Park, S. R., & Choi, B. H. (2013) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-013-1087-8 · Cited by 9
“Late administration of VEGF promotes angiogenesis and ameliorates functional deficits in the middle cerebral artery occlusion (MCAo) model, whereas early administration exacerbates BBB leakage and causes extensive brain edema.(65) On the other hand, angiogenin-1 (ANG1) has a role in maturation of newly formed vessels,…”
BackgroundThe Kinetic Change of the Serum Angiogenin Level in Patients with Acute Cerebral Infarction
Li, H., Guo, H., Cheng, M., Zhao, Y., & Jin, X. (2007) · European Neurology · doi:10.1159/000107944 · Cited by 9
Jesmin, S., Maeda, S., Mowa, C. N., Zaedi, S., Togashi, H., Prodhan, S. H., Yamaguchi, T., Yoshioka, M., Sakuma, I., Miyauchi, T., et al. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.07.023 · Cited by 9
“induce leakage of the blood–brain barrier, with resultant hemorrhagic transformation of the ischemic lesions (Zhang et al., 2000).”
BackgroundInfluentialMusco, H., Beecher, K., Chand, K. K., Colditz, P. B., & Wixey, J. A. (2023) · Developmental Neuroscience · doi:10.1159/000530492 · Cited by 7
de Oliveira, C. L. L., Ferreira, F. M., Puppin-Rontani, J., Puppin‐Rontani, R. M., & Pascon, F. M. (2025) · Odontology · doi:10.1007/s10266-025-01128-y · Cited by 8
Lech, W., Kot, M., Wełniak-Kamińska, M., Drabik, M., Bużańska, L., & Zychowicz, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-04269-w · Cited by 8
Magid-Bernstein, J. R., Yan, J., Herman, A. L., He, Z., Johnson, C. W., Beatty, H. E., Choi, R., Velazquez, S. E., Sorensen, G., Jayasundara, S., et al. (2025) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2025.108395 · Cited by 8
“41, 42 In one prior study which measured VEGF in the plasma and CSF of aSAH patients, the cytokine was found to be elevated in CSF from aSAH patients compared to control CSF and in aSAH patient CSF compared to plasma, but no differences were found between aSAH patient and control plasma.”
AL-Eitan, L. N., & Alahmad, S. Z. (2023) · Gene · doi:10.1016/j.gene.2023.147585 · Cited by 8
Integrated Strategies for Targeting Arteriogenesis and Angiogenesis After Stroke
Wang, J., Xiong, T., Wu, Q., & Qin, X. (2024) · Translational Stroke Research · doi:10.1007/s12975-024-01291-4 · Cited by 10
“VEGF enhances vascular permeability, which is associated with edema formation and an increased risk of hemorrhage, especially when administered during the hyperacute phase of a stroke [76, 77].”
Shinozaki, M., Nakamura, M., Konomi, T., Kobayashi, Y., Takano, M., Saito, N., Toyama, Y., & Okano, H. (2013) · Neuroscience Research · doi:10.1016/j.neures.2013.09.011 · Cited by 8
rAAV vector-mediated gene therapy for experimental ischemic stroke
Li, Z., & Wang, R. (2008) · Neurology India · doi:10.4103/0028-3886.41986 · Cited by 8
“It has been reported that early post-ischemic systemic delivery of VEGF increased BBB leakage and induced brain edema,[41] while VEGF antagonization with the high-affinity VEGF-binding protein mFlt(1-3)-IgG improved neurological outcome as well as reduced cerebral edema and infarct size.”
BackgroundYang, W., Zhang, L., Chen, S., Yao, Q., Chen, H., Zhou, J. W., Chen, W., He, L., & Zhang, Y. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/9654175 · Cited by 8
“+us far, the most compelling argument has been that VEGF increases BBB permeability in the early phase of ischemic stroke and subsequently facilitates neurovascular remodeling [63].”
BackgroundSelf-citationLi, Z., Wang, M., Gu, J., Zhao, L., Guo, Y., Zhang, Z., & Liu, X. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00890-7 · Cited by 8
Self-citationMemanishvili, T., Monni, E., Tatarishivili, J., Lindvall, O., Tsiskaridze, A., Kokaia, Z., & Tornero, D. (2019) · Biomedical Materials · doi:10.1088/1748-605x/aba4f6 · Cited by 8
Cerebral Damage after Stroke: The Role of Neuroplasticity as Key for Recovery
Muhammad, M., & Hassan, T. M. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95512 · Cited by 8
Mechanisms of Cerebral Angiogenesis in Health and Brain Pathology
Uspenskaya, Y. A., Morgun, A. V., Osipova, E. D., Пожиленкова, Е. А., & Salmina, A. B. (2022) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-022-01259-7 · Cited by 8
Bernstock, J. D., Verheyen, J., Huang, B. Y., Hallenbeck, J. M., & Pluchino, S. (2014) · InTech eBooks · doi:10.5772/58599 · Cited by 9
“Administration of other factors such as RA, bFGF, EGF, BDNF and VEGF have also been shown to enhance neurogenesis in similar disease models ultimately leading to enhanced recovery [177, 213, 311, 479-483].”
ResultThe Cerebral Microvasculature and Responses to Ischemia
del Zoppo, G. D., & Hamann, G. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5478-8.10002-8 · Cited by 9
Sargento‐Freitas, J., Pereira, A., Gomes, A., Amorim, P., Matos, T., Cardoso, C. M. P., da Silva, F. A. D. A., Cordeiro, G., Nunes, C., Galego, O., et al. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00302 · Cited by 8
“Nonetheless, this link shows an apparent time-dependent response with acute disruption of the blood–brain barrier and hemorrhagic transformation in the first hours after stroke, whereas enhancing effective neoangiogenesis with improved outcomes in the subacute stage (8, 15).”
BackgroundHong, Y., Yu, Q., Kong, Z., Wang, M., Zhang, R., Li, Y., & Liu, Y. (2020) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-20-329 · Cited by 8
“Compared with other therapeutic strategies such as the use vascular endothelial growth factor (VEGF) (31,32) and granulocyte-colony stimulating factor (G-CSF) (33-35), EPC transplantation holds more advantages.”
Self-citationRamli, Y., Alwahdy, A. S., Kurniawan, M., Juliandi, B., & Wuyung, P. E. (2018) · Journal of Stem Cells and Regenerative Medicine · doi:10.46582/jsrm.1402011 · Cited by 8
“On the other hand, this result was not found if it is given at 48 hours post-stroke([13,30]), therefore, transplantation was done in sub-acute period.”
BackgroundProtective Effects of Natrii Sulfas on Cerebral Focal Ischemia Induced by MCAO in Rats
Sohn, Y., Kang, H. C., Kim, K. S., Park, S., Sohn, N., Jung, H., & Kim, S. (2009) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x09006849 · Cited by 8
Etter, M. M., Martins, T. A., Kulsvehagen, L., Pössnecker, E., Duchemin, W., Hogan, S. A., Sanabria-Díaz, G., Müller, J., Chiappini, A., Rychen, J., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1385593/v1 · Cited by 8
Vasoregulatory Autoantibodies and Clinical Outcome After Ischemic Stroke—PROSCIS‐B
Liman, T., Siegerink, B., Piper, S. K., Catar, R. A., Moll, G., Riemekasten, G., Heidecke, H., Heuschmann, P. U., Elkind, M. S. V., Dragun, D., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.032441 · Cited by 7
“36 In our study, only IgG-type autoantibodies were measured.”
A half-century of VEGFA: from theory to practice
Quaggin, S. E. (2024) · Journal of Clinical Investigation · doi:10.1172/jci184205 · Cited by 7
“Zhang et al. (16) examined the role of VEGFA in the setting of ischemic stroke — an often irreversible and severe disease that is associated with long-lasting morbidity and mortality.”
BackgroundMinimally Invasive Syringe‐Injectable Hydrogel with Angiogenic Factors for Ischemic Stroke Treatment
Kim, D., Lee, J. W., Kim, Y., Choe, J., Kim, G., Ha, C. M., Kim, J. G., Song, K. H., & Yang, S. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202403119 · Cited by 7
Espin, A. T., Radabaugh, H. L., Treiman, S. M., Fitzsimons, S., Harvey, D. J., Chou, A., Lindbergh, C. A., Casaletto, K. B., Goldberger, L., Staffaroni, A. M., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adk3118 · Cited by 9
Thyroid Hormone T4 Alleviates Traumatic Brain Injury by Enhancing Blood–Brain Barrier Integrity
Khandelwal, M., Ying, Z., & Gómez‐Pinilla, F. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199632 · Cited by 9
“Stroke, brain injury, and other pathological diseases upregulate VEGF and promote vascular leakage and brain edema [66].”
Yao, Y., Shaligram, S. S., & Su, H. (2020) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64034-5.00005-5 · Cited by 8
Angiogenesis and Functional Recovery After Traumatic Brain Injury
Zhang, Y., Xiong, Y., Mahmood, A., Zhang, Z. G., & Chopp, M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8690-9_8 · Cited by 7
Self-citationWu, F., Wang, J., Dorman, B., Zeineddin, A., & Kozar, R. A. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00550-0 · Cited by 7
Brain Maturation as a Fundamental Factor in Immune-Neurovascular Interactions in Stroke
Martino, E. D., Rayasam, A., & Vexler, Z. S. (2023) · Translational Stroke Research · doi:10.1007/s12975-022-01111-7 · Cited by 7
“VEGF receptor inhibition after neonatal stroke was shown to reduce EC proliferation [118, 119].”
BackgroundThe protective effects of statins in traumatic brain injury
Pordel, S., McCloskey, A. P., Almahmeed, W. A., & Sahebkar, A. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00582-9 · Cited by 7
“BBB deterioration in a hypoxic environment is multifactorial, and linked to elevated NO and VEGF levels [101].”
Erdő, F., & Buschmann, I. R. (2007) · Orvosi Hetilap · doi:10.1556/oh.2007.27916 · Cited by 7
Katsumata, A., Sugiu, K., Tokunaga, K., Kusaka, N., Watanabe, K. A., Nishida, A., Namba, K., Hamada, H., NAKASHIMA, H., & Date, I. (2010) · Neurologia medico-chirurgica · doi:10.2176/nmc.50.449 · Cited by 8
Ara, J. E., Shukla, P., & Frank, M. (2012) · Journal of Neurochemistry · doi:10.1111/jnc.12110 · Cited by 7
(2005) · The Internet Journal of Neurology · doi:10.5580/24fd · Cited by 7
“the ischemic brain and reduces neurological deficits during stroke recovery [15].”
BackgroundInfluentialLi, N., & Jiang, Z. (2016) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2016.11.020 · Cited by 7
Qu, Y., Zhang, H., Li, H., Yu, L., Sun, Y. J., & Chen, Y. (2017) · Medical Science Monitor · doi:10.12659/msm.905206 · Cited by 7
“In the ischemic and hypoxic microenvironment, the expression level of angiogenesis-related incentives such as vascular endothelial growth factor (VEGF), transforming growth factor-b (TGF-b), angiogenin (ANG) [41], and many other growth factors, induced new vascular generation and collateral circulation.”
BackgroundThe cellular and molecular mechanisms of angiogenesis regulation in the brain
Черток, В. М., Захарчук, Н. В., & Черток, А. Г. (2017) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20171178243-55 · Cited by 7
Principles of bioreactor design for tissue engineering
Yu, H., Chong, S. K. M., Hassanbhai, A. M., Teng, Y., Balachander, G. M., Muthukumaran, P., Wen, F., & Teoh, S. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818422-6.00012-5 · Cited by 7
Falcone, J., Sohal, H. S., Kyriakides, T. R., & Bellamkonda, R. V. (2019) · Journal of Neural Engineering · doi:10.1088/1741-2552/ab1ef9 · Cited by 7
Kamishina, H., Cheeseman, J. A., & Clemmons, R. M. (2009) · Veterinary Research Communications · doi:10.1007/s11259-009-9213-8 · Cited by 7
“Vasoactive peptides such as VEGF ( Zhang et al. 2000; Chen et al. 2003; Wang et al. 2006) and BNP (Song et al. 2004) may also participate in the reparative processes after CNS injury by inducing angiogenesis and reducing secondary edema after injury.”
BackgroundEndogenous Neurogenesis, Oligodendrogenesis and Angiogenesis after Ischemic Brain Injury
Yamashita, T. (2012) · Journal of Neurology & Neurophysiology · doi:10.4172/2155-9562.s8-003 · Cited by 6
“These results seem to suggest that VEGF can be a promising agent for minimizing ischemic-related injury, although issues regarding its utility as a therapeutic agent remain because administration of VEGF at 1 hour after ischemia increased blood brain barrier leakage, and worsened brain edema [24].”
BackgroundMethodStroke and the Blood‐Brain Interface
Cipolla, M. J. (2006) · doi:10.1002/9783527611225.ch25 · Cited by 7
Battaglia, L., Dianzani, C., Muntoni, E., Marini, E., Bozza, A., Bordano, V., Ferraris, C., Garelli, S., Valsania, M. C., Terreno, E., et al. (2024) · Nanomedicine · doi:10.1080/17435889.2024.2434452 · Cited by 6
“It has been demonstrated that VEGF-α, associated with the high angiogenic nature of high-grade gliomas, increases the BBB permeability, by stimulating angiogenesis in response to hypoxia, through the hypoxia induced factors (HIF) [5,46].”
Brain metastasis localized to the same area of infarction: illustrative case
Atallah, O., & Chaurasia, B. K. (2023) · Journal of Neurosurgery Case Lessons · doi:10.3171/case23325 · Cited by 6
“VEGF’s main job is to encourage the growth of new blood vessels (angiogenesis) in response to damaged or ischemic (not enough blood flow) tissue.(23) However, this elevated VEGF level may unintentionally help metastatic FIG.”
Background
Metadata
- Authors
- Zhang, Z. G., Zhang, L., Jiang, Q., Zhang, R., Davies, K., Powers, C., Bruggen, N. V., & Chopp, M.
- Affiliations
- Henry Ford Health (US)
- Henry Ford Hospital (US)
- Genentech (US)
- Oakland University (US)
- Corresponding author
- Chopp, Michael
- Venue
- Journal of Clinical Investigation
- Published
- 2000-10-01
- Volume
- 106
- Issue
- 7
- Pages
- 829-838
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC517814
- OpenAlex
- W2084498863
- Cited by
- 1,296
- References
- 75
- Citations by year
- 2026: 32 · 2025: 49 · 2024: 53 · 2023: 52 · 2022: 64 · 2021: 73 · 2020: 58 · 2019: 42 · 2018: 59 · 2017: 59 · 2016: 61 · 2015: 49 · 2014: 70 · 2013: 70 · 2012: 64
- FWCI
- 13.44
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ns033627-08)
- National Institute of Neurological Disorders and Stroke (P01NS23393, R01NS-33627, P01NS023393)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- vascular endothelial growth factor, angiogenesis, blood-brain barrier disruption, cerebral ischemia, hemorrhagic transformation, ischemic penumbra, neurological recovery, VEGF inhibition, stroke
- MeSH terms
- Animals, Blood-Brain Barrier, Brain Ischemia, Image Processing, Computer-Assisted, Lymphokines, Magnetic Resonance Imaging, Male, Microcirculation, Neovascularization, Pathologic, Regional Blood Flow, Endothelial Growth Factors, Treatment Outcome, Rats, Wistar, Stroke, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review